We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGM icon
1526
Federal Agricultural Mortgage
AGM
$2.4B
-15,459
Closed -$2.29M
AGNC icon
1527
PUT
AGNC Investment
AGNC
$12.9B
-108,500
Closed -$1.09M
AGX icon
1528
Argan
AGX
$7.03B
-8,235
Closed -$4.49M
AIN icon
1529
Albany International
AIN
$1.68B
-13,987
Closed -$730K
AIZ icon
1530
Assurant
AIZ
$14B
-6,593
Closed -$1.44M
ALDX icon
1531
Aldeyra Therapeutics
ALDX
$91.7M
-167,604
Closed -$283K
ALLO icon
1532
Allogene Therapeutics
ALLO
$722M
-64,313
Closed -$157K
ALLT icon
1533
Allot
ALLT
$366M
-74,908
Closed -$499K
ALLY icon
1534
Ally Financial
ALLY
$13.1B
-329,532
Closed -$12.9M
ALT icon
1535
Altimmune
ALT
$605M
-48,619
Closed -$150K
ALVO icon
1536
Alvotech
ALVO
$1.5B
-32,159
Closed -$110K
ALV icon
1537
Autoliv
ALV
$9.18B
-230,833
Closed -$24.3M
AMAL icon
1538
Amalgamated Financial
AMAL
$1.46B
-46,697
Closed -$1.82M
AMBA icon
1539
Ambarella
AMBA
$3.23B
-8,677
Closed -$447K
AMKR icon
1540
CALL
Amkor Technology
AMKR
$12.5B
-3,000
Closed -$135K
AMT icon
1541
American Tower
AMT
$81.9B
-119,359
Closed -$20.6M
ANAB icon
1542
AnaptysBio
ANAB
$1.71B
-7,260
Closed -$403K
AN icon
1543
AutoNation
AN
$6.6B
-38,667
Closed -$7.55M
ANDE icon
1544
Andersons Inc
ANDE
$2.31B
-96,511
Closed -$6.93M
ANGI icon
1545
Angi Inc
ANGI
$200M
-136,266
Closed -$933K
ANNX icon
1546
Annexon
ANNX
$961M
-14,938
Closed -$82.8K
AON icon
1547
Aon
AON
$75.3B
-6,843
Closed -$2.21M
APD icon
1548
Air Products & Chemicals
APD
$67.9B
-12,092
Closed -$3.51M
APH icon
1549
Amphenol
APH
$194B
-126,186
Closed -$15.9M
APLD icon
1550
Applied Digital
APLD
$7.74B
-103,156
Closed -$2.45M

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.